Oncolytics Biotech Q3 Results Preview: EPS Estimate (0.05) USD
Oncolytics Biotech is scheduled to report Q3'26 results October 30; revenue is estimated at zero and EPS at (0.05) USD. The release time is not specified.
ONCY (Oncolytics Biotech Inc.) is set to announce its Q3'26 results on October 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.05) USD. Learn more details at ONCY Fina…